anti-cytomegalovirus immunoglobulin (Blue Blood Biotech)

N/A

Report date: 2025/03/14 18:13:23

Base Information

Drug Nameanti-cytomegalovirus immunoglobulin (Blue Blood Biotech)
Drug Alias NameAnti-CMV IVIG
ClassificationBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCytomegalovirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBlue Blood Biotech Corp
China Registration ClassN/A

Develop Information

Active CompaniesBlue Blood Biotech Corp
Inactive CompaniesN/A
Active IndicationsCytomegalovirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A